Trial Profile
A Randomized Controlled Double-blinded Study Comparing the Intraoperative Injection of Lymphatic Mapping Agents Tc 99m Tilmanocept to Tc 99m Filtered Sulfur Colloid in Breast Cancer Patients Undergoing Breast Conservation and Sentinel Lymph Node Biopsy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Tc 99m tilmanocept (Primary) ; Tc 99m sulfur colloid
- Indications Early breast cancer
- Focus Diagnostic use
- 29 Jun 2017 New trial record